- Home
- DDD vs CATX Comparison
DDD vs CATX Comparison
Compare DDD & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DDD
- CATX
- Stock Information
- Founded
- DDD 1986
- CATX 1983
- Country
- DDD United States
- CATX United States
- Employees
- DDD N/A
- CATX N/A
- Industry
- DDD Computer peripheral equipment
- CATX Medical/Dental Instruments
- Sector
- DDD Technology
- CATX Health Care
- Exchange
- DDD Nasdaq
- CATX Nasdaq
- Market Cap
- DDD 210.1M
- CATX 239.0M
- IPO Year
- DDD N/A
- CATX N/A
- Fundamental
- Price
- DDD $1.64
- CATX $3.82
- Analyst Decision
- DDD Hold
- CATX Strong Buy
- Analyst Count
- DDD 3
- CATX 11
- Target Price
- DDD $3.50
- CATX $12.90
- AVG Volume (30 Days)
- DDD 5.6M
- CATX 1.3M
- Earning Date
- DDD 08-28-2025
- CATX 08-13-2025
- Dividend Yield
- DDD N/A
- CATX N/A
- EPS Growth
- DDD N/A
- CATX N/A
- EPS
- DDD N/A
- CATX N/A
- Revenue
- DDD $431,756,000.00
- CATX $1,471,000.00
- Revenue This Year
- DDD N/A
- CATX N/A
- Revenue Next Year
- DDD $3.55
- CATX N/A
- P/E Ratio
- DDD N/A
- CATX N/A
- Revenue Growth
- DDD N/A
- CATX N/A
- 52 Week Low
- DDD $1.32
- CATX $1.60
- 52 Week High
- DDD $5.00
- CATX $16.55
- Technical
- Relative Strength Index (RSI)
- DDD 47.70
- CATX 61.22
- Support Level
- DDD $1.62
- CATX $3.33
- Resistance Level
- DDD $1.84
- CATX $4.26
- Average True Range (ATR)
- DDD 0.10
- CATX 0.32
- MACD
- DDD 0.02
- CATX 0.01
- Stochastic Oscillator
- DDD 57.29
- CATX 76.19
About DDD 3D Systems Corporation
3D Systems Corp provides comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, advanced manufacturing and applications engineering. The company's segments include Healthcare Solutions and Industrial Solutions. It generates maximum revenue from the Industrial segment. It conducts business through various offices and facilities located throughout the Americas, EMEA, and APAC; generating a vast majority of revenues from the Americas.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.